EP4076465
ONCE DAILY CANCER TREATMENT REGIMEN WITH A PRMT5 INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.12.2020EP published:
15.11.2023EP application number:
20828324.2
EPO information:
European Patent Register
Max expiry date:
14.12.2040
Title in English:
ONCE DAILY CANCER TREATMENT REGIMEN WITH A PRMT5 INHIBITORLanguage of the patent:
English
Timeline
Today
15.12.2020EP application
15.11.2023EP Publication
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
LI, MengAddress:
San Diego, California 92121, US
Name:
LIAO, Kai-HsinAddress:
San Diego, California 92121, US
Name:
YAMAZAKI, ShinjiAddress:
San Diego, California 92130, US
Priority
Number:
201962949688 PDate:
18.12.2019Country:
US
Number:
202063066755 PDate:
17.8.2020Country:
US
Number:
202063108745 PDate:
2.11.2020Country:
US
Classification
Categories:
A61K 31/519, A61K 31/337, A61P 35/00, A61K 9/00, A61K 39/00, A61K 9/20